Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sekihiro Tamaki

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|September 11, 2010
Comparative assessment of empirical and physiological approaches on predicting human clearancesSekihiro Tamaki, Hiroshi Komura, Motohiro Kogayu, et al.
Clinical Pharmacology in Drug Development|February 20, 2019
Pharmacokinetics, Food Effect, Ketoconazole Interaction, and Safety of JTK-853, a Novel Nonnucleoside HCV Polymerase Inhibitor, After Ascending Single and Multiple Doses in Healthy SubjectsSekihiro Tamaki, Tsutomu Shibata, Thomas Hunt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2007
Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humansYoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, et al.
Toxicology and Applied Pharmacology|July 18, 2012
Comparative study on 2,2',4,5,5'-pentachlorobiphenyl-mediated decrease in serum thyroxine level between C57BL/6 and its transthyretin-deficient miceYoshihisa Kato, Sekihiro Tamaki, Koichi Haraguchi, et al.
Drug Metabolism and Pharmacokinetics|December 28, 2012
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomesShingen Misaka, Keisuke Kawabe, Satomi Onoue, et al.
Journal of Applied Toxicology : JAT|September 10, 2019
Kanechlor 500-mediated changes in serum and hepatic thyroxine levels primarily occur in a transthyretin-unrelated mannerYoshihisa Kato, Sekihiro Tamaki, Koichi Haraguchi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|September 11, 2010
Comparative assessment of empirical and physiological approaches on predicting human clearancesSekihiro Tamaki, Hiroshi Komura, Motohiro Kogayu, et al.
Clinical Pharmacology in Drug Development|February 20, 2019
Pharmacokinetics, Food Effect, Ketoconazole Interaction, and Safety of JTK-853, a Novel Nonnucleoside HCV Polymerase Inhibitor, After Ascending Single and Multiple Doses in Healthy SubjectsSekihiro Tamaki, Tsutomu Shibata, Thomas Hunt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2007
Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humansYoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, et al.
Toxicology and Applied Pharmacology|July 18, 2012
Comparative study on 2,2',4,5,5'-pentachlorobiphenyl-mediated decrease in serum thyroxine level between C57BL/6 and its transthyretin-deficient miceYoshihisa Kato, Sekihiro Tamaki, Koichi Haraguchi, et al.
Drug Metabolism and Pharmacokinetics|December 28, 2012
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomesShingen Misaka, Keisuke Kawabe, Satomi Onoue, et al.
Journal of Applied Toxicology : JAT|September 10, 2019
Kanechlor 500-mediated changes in serum and hepatic thyroxine levels primarily occur in a transthyretin-unrelated mannerYoshihisa Kato, Sekihiro Tamaki, Koichi Haraguchi, et al.
Pageof 1